Priority Date: 17.06.16 (US 201662351749P)

PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF

  • Application ID: EP17814169
  • Status: Request for examination was made

Attorney

Employment test 51 - 200 employees
Company dna barker brettell llp
no operation time available
Headquarter in Birmingham and 7 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Barker Brettell LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 226 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 17.06.2016 - Priority Date (US 201662351749P)
  • 21.12.2017 - Publication A1 (WO2017218892)
  • 24.04.2019 - Publication A1 (EP3471730)

IPC Classification